Since 2021, LCL has been carrying out internal awareness-raising actions and supporting research by allowing its employees to participate in solidarity races, or its customers to contribute through commercial offers accompanied by donations.
In 2024, LCL remains loyal to Gustave Roussy, the leading cancer center in Europe, and is involved in different ways to raise funds.
Social funds committed
Thanks to the marketing of two new social debt securities, LCL Care Impact and LCL Solidaire & Santéintended for individual customers and private banks, donations will very soon be awarded to Gustave Roussy.
These donations will help develop the program 50 shades of pinkwhich consists of adapting medical protocols to preserve the quality of life of women suffering from breast cancer.
Employees on track with Odyssea, solidarity race against breast cancer
In 2024, LCL renews its mobilization with Odyssea, which funds research against breast cancer by organizing races in France.
More than 500 employees of Ile-de-France and the regions of Marseille and Nantes are mobilizing running for the fight against breast cancer. Thanks to their energy, donations which will be made to AP-HM (Public Assistance – Marseille Hospitals) and to Gustave Roussy.
LCL, loyal partner of Gustave Roussy
A Gustave Roussy, researchers and doctors work together to provide therapeutic solutions for all pathologies, particularly breast cancer. The Breast Pathology Committee treats more than 10,000 women with breast cancer each year.
LCL specifically supports 2 programs:
The “Compass” program
This program is aimed at patients with an early relapse of triple negative breast cancer, that is to say occurring during the initial treatment of localized cancer or within 12 months following this treatment, and having not yet received treatment during metastatic recurrence.
The purpose of Compass is to iquickly identify an effective treatment metastatic triple negative breast cancer in early relapse,identify factors associated with response and resistance to treatments and better understand the biological characteristics of the disease.
LCL has supported this program for 2 years now. The funds collected made it possible to:
- The recruitment of a medical oncologist and the recruitment of a project manager
- The design of a site aimed at raising awareness of the program and facilitating the inclusion of patients followed in other centers throughout France.
- Cooperation with 2 fundamental research and biological analysis laboratories which allows us to better understand the evolution of the disease.
The “50 shades of pink” program
This program consists of adapting medical protocols to preserve the quality of life of women suffering from breast cancer.
More than 30,000 patients per yearsuffering from breast cancer, present an alteration in their quality of life linked to the chronic toxicity of treatments.
The research teams aim toidentify the individual risk of relapse from diagnosis and of understand the biological mechanisms behind toxicities in order to better prevent them.
